Experts Forecast Cancer Research and Treatment Advances in 2023
The year 2022 will be remembered as the time when the emergency phase of the COVID-19 pandemic began to...
AACR Annual Meeting 2023: NFL Star Rodney McLeod and Erika McLeod Partner with AACR in Support of Cancer Research
The American Association for Cancer Research (AACR) was thrilled to welcome Super Bowl Champion Rodney McLeod Jr. and Erika...
AACR Annual Meeting 2023: Closing Plenary Highlights Research Breakthroughs and Next Steps
“Where is the field of cancer research going?” posed Robert Vonderheide, MD, DPhil, as he welcomed attendees to “AACR...
AACR Annual Meeting 2023: A Recap of AACR Blog Posts
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...
AACR Annual Meeting 2023: Phase III Immunotherapy Trials Offer Hope for Patients With Lung, Liver, and Biliary Tract Cancers
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
AACR Annual Meeting 2023: Designing, Targeting, and Delivering Novel Cancer Drugs
The era of targeted cancer therapy has fundamentally transformed the way several cancers are treated and has provided new...
AACR Annual Meeting 2023: The Past, Present, and Future of Targeted Therapies for Pediatric Cancer
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
AACR Annual Meeting 2023: Boosting Diversity in Clinical Trials (Part 2, Community Engagement)
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...
AACR Annual Meeting 2023: Opening Plenary Covers Breadth of Cancer Research
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
Young Scientists from Around the World Benefit from AACR Support, Attendance at Annual Meeting
For the past five years, cohorts of talented young researchers from around the world have participated in the AACR...
AACR Annual Meeting 2023: Clinical Trials of Therapeutic Cancer Vaccines Show Promise
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
AACR Annual Meeting 2023: Demystifying Immune Ecosystems
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
AACR Annual Meeting 2023: The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
AACR Annual Meeting 2023: NCI Director Shares National Cancer Plan
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
AACR Annual Meeting 2023: Therapy Advances for Patients With Rare Melanoma Types
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
World Cancer Day: AACR’s Efforts to Close the Care Gap
The AACR supports the mission of World Cancer Day 2024 to Close the Care Gap, which it has worked...
Annual Meeting 2023: Boosting Diversity in Clinical Trials (Part 1, Trial Design)
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
Supporting Undergraduate Investigators at the AACR Annual Meeting 2024
Experience the annual undergraduate poster competition at the AACR Annual Meeting through photos.
AACR Annual Meeting 2023: Navigating the Challenges of Cancer Treatment During Pregnancy
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
AACR Annual Meeting 2023: Beating KRAS
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
The Five ‘W’s’ (and ‘H’) of SABCS 2023
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one...
AACR Annual Meeting 2023: Understanding Immune Suppression in Brain Metastases
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
Honoring National Cancer Survivors Month, Recognizing the AACR Scientist↔Survivor Program®’s Positive Impact
Editor’s note: As we honor National Cancer Survivor Month, we are also recognizing the AACR Scientist↔Survivor Program’s positive impact...
AACR Shares Mission of World Cancer Day: Ending Disparities
World Cancer Day is February 4, 2023. This annual initiative by the Union for International Cancer Control (UICC) aims...
FDA Approvals in Oncology: July-September 2023
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
FDA Approvals in Oncology: April-June 2023
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
NCI Director Introduces New Era of Cancer Research
NCI Director Kimryn Rathmell evoked Taylor Swift to present her vision of the 360 era for cancer research.
Young Researchers Share Benefits of Global Scholar-in-Training Program
Four of the 2023 GSITA recipients explain how the program has benefited their careers.
Accelerated Approval of Cancer Drugs: How Many Verify Clinical Benefit?
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
Frontiers in Cancer Science: A Stellar Conference in Singapore
by Ashok Venkitaraman, MBBS, PhD Singapore will hold its 15th Frontiers in Cancer Science (FCS) conference November 6-8 at...